You have successfully sign out
Loading...
Harrow Health, Inc. 8.625% Senior Notes due 2026
HROWL
Company Description
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Â
NASDAQ
25.38USD
-0.02Â ( -0.07%)
Pre-market 24.92$-0.47 (-1.83%)Market Closed (as of Apr 11, 20:00 EDT)
Relative Strenght
74
Volume Buzz
1%
Earning Acce
Yes
Dist 52w H.
1%
